Comparison of lateral flow technology and galactomannan and (1→3)-β-D-glucan assays for detection of invasive pulmonary aspergillosis

Nathan P. Wiederhold, Christopher R. Thornton, Laura K. Najvar, William R. Kirkpatrick, Rosie Bocanegra, Thomas F. Patterson

Research output: Contribution to journalArticle

37 Scopus citations


We compared a lateral flow device to galactomannan and (1→3)-β-D- glucan assays to detect invasive aspergillosis in an established guinea pig model of pulmonary disease. The lateral flow device became positive earlier (day 3) than the (1→3)-β-D-glucan and galactomannan assays (day 5), with all samples positive by each assay on day 7.

Original languageEnglish (US)
Pages (from-to)1844-1846
Number of pages3
JournalClinical and Vaccine Immunology
Issue number12
Publication statusPublished - Dec 1 2009


ASJC Scopus subject areas

  • Immunology and Allergy
  • Immunology
  • Clinical Biochemistry
  • Microbiology (medical)

Cite this